Finance

Lists
NHI:NYSE
National Health Investors Inc
$74.49
+0.43%
(+0.32) 1D
Aug 20, 12:06:16 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NHI...
Open
$74.06
High
$74.73
Low
$74.06
Mkt. cap
3.66B
Avg. vol.
391.10K
Volume
32.65K
Dividend
4.97%
Quarterly dividend
$0.93
Ex-dividend date
Jun 30, 2026
P/E ratio
21.56
52-wk high
$91.38
52-wk low
$67.94
EPS
$3.46
Beta
0.50
Shares outstanding
49.11M
No. of employees
32
Open
$74.06
High
$74.73
Low
$74.06
Mkt. cap
3.66B
Avg. vol.
391.10K
Volume
32.65K
Dividend
4.97%
Quarterly dividend
$0.93
Ex-dividend date
Jun 30, 2026
P/E ratio
21.56
52-wk high
$91.38
52-wk low
$67.94
EPS
$3.46
Beta
0.50
Shares outstanding
49.11M
No. of employees
32
News stories
From web sources and news partners
About National Health Investors Inc
CEO-
Employees32
Founded1991
HeadquartersMurfreesboro, Tennessee, United States
SectorReal estate investment trust
Websitenhireit.com
Analyst ratings
Based on 6 analysts giving stock ratings to NHI in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for NHI in the last 3 months.
Highest
Current $74.49
$91.00 (+22.16%)
Average
$84.00 (+12.77%)
Lowest
$79.00 (+6.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$90.00
+20.8%
08/14/2026
Michael Lewis
Truist Financial
Buy
Maintained
-
-
08/11/2026
John Kilichowski
Wells Fargo
Hold
Reiterated
$79.00
+6.1%
08/11/2026
Omotayo Okusanya
Deutsche Bank
Hold
Maintained
$80.00
+7.4%
06/25/2026
Juan C. Sanabria
BMO Capital
Buy
Maintained
$80.00
+7.4%
06/15/2026
Farrell Granath
Bank of America Securities
Buy
Maintained
$91.00
+22.2%
06/10/2026
Last report
Aug 11, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.15 / $4.57
-74.82%miss
Revenue / Est. (USD)
121.32M / 112.51M
+7.83%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
89.92M
107.48M
115.13M
121.32M
Cost of goods sold
18.86M
26.00M
30.92M
36.44M
Cost of revenue
18.86M
26.00M
30.92M
36.44M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.44M
7.61M
8.16M
9.27M
Operating expense
26.90M
29.59M
32.06M
35.03M
Total operating expenses
45.77M
55.59M
62.98M
71.47M
Operating income
44.15M
51.89M
52.14M
49.85M
Other non operating income
-
-
35.00K
86.00K
EBT including unusual items
32.48M
37.80M
39.75M
56.09M
EBT excluding unusual items
30.39M
37.62M
37.14M
34.12M
Income tax expense
-
-
-
732.00K
Effective tax rate
-
-
-
1.30%
Other operating expenses
244.00K
324.00K
215.00K
213.00K
Net income
32.86M
38.16M
40.10M
55.67M
Net profit margin
36.55%
35.51%
34.83%
45.89%
Earnings per share
0.69
0.76
0.77
1.15
Interest and investment income
-
-
-
-
Interest expense
-13.77M
-14.26M
-15.04M
-15.81M
Net interest expenses
-13.77M
-14.26M
-15.04M
-15.81M
Depreciation and amortization charges
20.22M
21.65M
23.69M
25.55M
EBITDA
64.37M
73.54M
75.84M
75.40M
Gain or loss from assets sale
-113.00K
-119.00K
-2.61M
-21.97M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps